Mechanisms underlying neurocognitive dysfunctions in recurrent major depression

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 1535-1547

  Gałecki, Piotr ^a   Talarowska, Monika ^a   Anderson, George ^b   Berk, Michael ^c,d,e,f   Maes, Michael ^f,g,h  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b CRC Scotland and London   (United Kingdom)

^c ORYGEN RESEARCH CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^f DEAKIN UNIVERSITY   (Australia)

^g CHULALONGKORN UNIVERSITY   (Thailand)

^h STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Cognition; Depression; Inflammation; Neurogenesis; Oxidants

Indexed keywords

ANTIOXIDANT; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN;

APOPTOSIS; ARTICLE; ATTENTION; AUTOIMMUNITY; CIRCADIAN RHYTHM SLEEP DISORDER; COGNITIVE DEFECT; DISEASE ASSOCIATION; FLUENCY DISORDER; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM MEMORY; MAJOR DEPRESSION; MILD COGNITIVE IMPAIRMENT; MULTIPLE SCLEROSIS; NITROSATIVE STRESS; OXIDATIVE STRESS; PSYCHOMOTOR RETARDATION; RECURRENT DISEASE; SCHIZOPHRENIA; SHORT TERM MEMORY; CIRCADIAN RHYTHM; COMPLICATION; EXECUTIVE FUNCTION; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; MEMORY; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; NEUROCOGNITIVE DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE;

APOPTOSIS; ATTENTION; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; EXECUTIVE FUNCTION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; MEMORY; NEUROCOGNITIVE DISORDERS; NEUROGENESIS; OXIDATIVE STRESS; PITUITARY-ADRENAL SYSTEM; PSYCHOMOTOR PERFORMANCE; REACTIVE OXYGEN SPECIES; TRYPTOPHAN;

EID: 84930615773     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893176     Document Type: Article

References (124)

1. Rosenberg PB, Mielke MM, Xue QL, Carlson MC: Depressive symptoms predict incident cognitive impairment in cognitive healthy older women. Am J Ger Psych, 2010; 18: 204–11
2. Panza F, Frisardi V, Capurso C et al: Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry, 2010; 18(2): 98–116
3. Leonard BE: Inflammation, depression and dementia: are they connected? Neurochem Res, 2007; 32(10): 1749–56
4. Papakostas GI: Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice. J Clin Psychiatry, 2014; 75(1): 8–14
5. Modrego PJ, Ferrandez J: Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol, 2004; 61: 1290–93
6. Gualtieri T, Johnson L, Benedict K: Neurocognition in depression: patients on and off medication versus healthy comparison subjects. J Neuropsychiatry Clin Neurosci, 2006; 18(2): 217–26
7. Neu P, Bajbouj M, Schilling A et al: Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities. J Psychiatr Res, 2005; 39: 129–35
8. Funderud I, Lovstad M, Lindgren M et al: Preparatory attention after lesions to the lateral or orbital prefrontal cortex an event related potentials study. Brain Res, 2013; 1527: 174–88
9. Vasques PE, Moraes H, Silveira H et al: Acute exercise improves cognition in the depressed elderly: the effect of dual-tasks. Clinics (Sao Paulo), 2011; 66(9): 1553–57
10. Ng J, Chan HY, Schlaghecken F: Dissociating effects of subclinical anxiety and depression on cognitive control. Adv Cogn Psychol, 2012; 8(1): 38–49
11. Vinkers D, Gussekloo J, Stek M et al: Temporal relation between depression and cognitive impairment in old age: prospective population based study. BMJ, 2004; 329: 881–91
12. Castaneda AE, Marttunen M, Suvisaari J et al: The effect of psychiatric comorbidity on cognitive functioning in a population-based sample of depressed young adults. Psychol Med, 2010; 40: 29–39
13. Schaub A, Neubauer N, Mueser KT et al: Neuropsychological functioning in inpatients with major depression or schizophrenia. BMC Psychiatry, 2013; 13: 203
14. Airaksinen E, Wahlin A, Larsson M, Forsell Y: Cognitive and social functioning in recovery from depression: results from a population-based threeyear follow-up. Journal Affect Disord, 2006; 96: 107–10
15. Luo LL, Chen X, Chai Y et al: A distinct pattern of memory and attention deficiency in patients with depression. Chin Med J (Engl), 2013; 126(6): 1144–49
16. Wang J, Kim JM, Donovan DM et al: Significant modulation of mitochondrial electron transport system by nicotine in various rat brain regions. Mitochondrion, 2009; 9(3): 186–95
17. McBride M: I’m not crazy, I’m just depressed: differential diagnosis of dementia vs. depression. Kans Nurse, 2006; 81(9): 4–7
18. Anderson G, Maes M: Reconceptualizing adult neurogenesis: role for sphingosine- 1-phosphate and fibroblast growth factor-1 in co-ordinating astrocyte- neuronal precursor interactions. CNS Neurol Disord Drug Targets, 2014; 13(1): 126–36
19. Andersson C, Lindau M, Almkvist O et al: Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients. Dement Geriatr Cogn Disord, 2006; 21(4): 251–59
20. Bird C, Burgess N: The hippocampus and memory: insights from spatial processing. Nature Reviews. Nat Rev Neurosci, 2008; 9(3): 182–94
21. Rutishauser U, Schuman E, Mamelak A: Activity of human hippocampal and amygdala neurons during retrieval of declarative memories. Proc Natl Acad Sci USA, 2008; 105(1): 329–34
22. McGinty VB, Grace AA: Activity-dependent depression of medial prefrontal cortex inputs to accumbens neurons by the basolateral amygdala. Neuroscience, 2009; 162(4): 1429–36
23. Talarowska M, Florkowski A, Zboralski K et al: Auditory-verbal declarative and operating memory among patients suffering from depressive disorders – preliminary study. Adv Med Sci, 2010; 55(2): 317–27
24. Martinez-Aran A, Vieta E, Reinares M et al: Cognitive functions across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry, 2004; 161: 262–70
25. Kałwa A: Cognitive dysfunctions in bipolar disorders. Psychiatr Pol, 2011; XLV(6): 901–10
26. Harvey PO, Fossati P, Pochon JB et al: Cognitive control and brain resources in major depression: an fMRI study using the n-back task. Neuroim, 2005; 26: 860–69
27. Joormann J, Gotlib IH: Updating the contents of working memory in depression: interference from irrelevant negative material. J Abnorm Psychol, 2008; 117(1): 182–92
28. Hugdahl K, Rund BR, Lund A et al: Brain activation measured with fMRI during a mental arithmetic task in schizophrenia and major depression. Am J Psychiatry, 2004; 161: 286–93
29. Pilhatsch M, Vetter NC, Hubner T et al: Amygdala-function perturbations in healthy mid-adolescents with familial liability for depression. J Am Acad Child Adolesc Psychiatry, 2014; 53(5): 559–68
30. Uekermann J, Abdel-Hamid M, Lehmkamper C et al: Perception of affective prosody in major depression: A link to executive functions? J Int Neuropsychol Soc, 2008; 14: 552–61
31. Schlosser N, Mensebach C, Rullkotter N et al: Selective attention in depression: influence of emotionality and personal relevance. J Nerv Ment Dis, 2011; 199(9): 696–702
32. Watkins E, Brown R: Rumination and executive function in depression: an experimental study. J Neurol Neurosurg Psychiatry, 2002; 72(3): 400–3
33. Talarowska M, Florkowski A, Gałecki P et al: Cognitive functions and depression. Psychiatr Pol, 2009; 43(1): 31–40
34. Badre D, Poldrack RA, Pare-Blagoev EJ et al: Dissociable controlled retrieval and generalized selection mechanisms in ventrolateral prefrontal cortex. Neuron, 2005; 47(6): 907–18
35. Jeste D, Heaton S: Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia. Am J Psychiatry, 1996; 153(4): 490–96
36. Kucharska-Pietura K, David AS: The perception of emotional chimeric faces in patients with depression, mania and unilateral brain damage. Psychol Med, 2003; 33: 739–45
37. Jenness JL, Hankin BL, Young JF, Gibb BE: Misclassification and Identification of Emotional Facial Expressions in Depressed Youth: A Preliminary Study. J Clin Child Adolesc Psychol, 2014; 14: 1–7
38. Lanting S, Haugrud N, Crossley M: The effect of age and sex on clustering and switching during speeded verbal fluency tasks. J Int Neuropsychol Soc, 2009; 15: 196–204
39. Lavender A, Watkins E: Rumination and future thinking in depression. Br J Clin Psychol, 2004; 43: 129–42
40. Herrmann LL, Goodwin GM, Ebmeier KP: The cognitive neuropsychology of depression in the elderly. Psychol Med, 2007; 37(12): 1693–702
41. Alosco ML, Spitznagel MB, Cohen R et al: Reduced cerebral perfusion predicts greater depressive symptoms and cognitive dysfunction at a 1-year follow-up in patients with heart failure. Int J Geriatr Psychiatry, 2014; 29(4): 428–36
42. Okada G, Okamoto Y, Morinobu S et al: Attenuated left prefrontal activation during a verbal fluency task in patients with depression. Neuropsychobiology, 2003; 47(1): 21–26
43. Tsujii N, Akashi H, Mikawa W et al: Discrepancy between self- and observer- rated depression severities as a predictor of vulnerability to suicide in patients with mild depression. J Affect Disord, 2014; 161: 144–49
44. Birchler-Pedross A, Frey S, Chellappa SL et al: Higher frontal EEG synchronization in young women with major depression: a marker for increased homeostatic sleep pressure? Sleep, 2011; 34(12): 1699–706
45. Germain A, Kupfer DJ: Circadian rhythm disturbances in depression. Hum Psychopharmacol, 2008; 23: 571–85
46. Watson NF, Harden KP, Buchwald D et al: Sleep duration and depressive symptom ms: a gene-environment interaction. Sleep, 2014; 37(2): 351–58
47. Zhao Q, Peng C, Wu X et al: Maternal Sleep Deprivation Inhibits Hippocampal Neurogenesis Associated with Inflammatory Response in Young Offspring Rats. Neurobiol Dis, 2014; 68: 57–65
48. Wetterberg L: The relationship between the pineal gland and the pituitary- adrenal axis in health, endocrine and psychiatric conditions. Psychoneuroendocrinology, 1983; 8(1): 75–80
49. Hansen MV, Madsen MT, Hageman I et al: The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebocontrolled, double-blinded trial. BMJ Open, 2012; 2(1): 000647
50. Sharma AK, Mehta AK, Rathor N et al: Melatonin attenuates cognitive dysfunction and reduces neural oxidative stress induced by phosphamidon. Fundam Clin Pharmacol, 2013; 27(2): 146–51
51. Sugden D, Cena V, Klein DC: Hydroxyindole O-methyltransferase. Hydroxyindole O-methyltransferase. Methods Enzymol, 1987; 142: 590–96
52. Reiter RJ, Tan DX, Terron MP et al: Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol, 2007; 54(1): 1–9
53. Muller DJ, Schulze TG, Jahnes E et al: Association between a polymorphism in the pseudoautosomal X-linked gene SYBL1 and bipolar affective disorder. Am J Med Genet, 2002; 114(1): 74–78
54. Talarowska M, Szemraj J, Zajączkowska M, Gałecki P: ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder. Med Sci Monit, 2014; 20: 905–12
55. Nedzvetsky VS, Nerush PA, Kirichenko SV: Effect of Melatonin on Cognitive Ability of Rats and Expression of NCAM in Brain Structures in Streptozotocin- Induced Diabetes. Neurophysiol, 2003; 35(6): 422–27
56. Polimeni G, Esposito E, Bevelacqua V et al: Role of melatonin supplementation in neurodegenerative disorders. Front Biosci (Landmark Ed), 2014; 19: 429–46
57. Laborie S: Effect of bright light and melatonin on cognitive and non-cognitive function. Cah Annee Gerontol, 2010; 2: 194–98
58. Anderson G, Maes M: Local Melatonin Regulates Inflammation Resolution: A Common Factor in Neurodegenerative, Psychiatric and Systemic Inflammatory Disorders. CNS Neuro Dis-Dr Tar [in press]
59. Ramirez-Rodriguez G, Vega-Rivera NM, Benitez-King G et al: Melatonin supplementation delays the decline of adult hippocampal neurogenesis during normal aging of mice. Neurosci Lett, 2012; 530(1): 53–58
60. Rothman SM, Mattson MP: Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases. Neuromol Med, 2012; 14: 194–204
61. Baydas G, Ozer M, Yasar A et al: Melatonin improves learning and memory performances impaired by hyperhomocysteinemia in rats. Brain Res, 2005; 1046(1–2): 187–94
62. Anderson G, Maes M: Multiple Sclerosis: The Role of Melatonin and N-acetylserotonin. Multiple Sclerosis & Related Disorders, 2014 [in press].
63. Liu YJ, Meng FT, Wang LL et al: Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells. J Pineal Res, 2012; 52(4): 397–402
64. Muxel SM, Pires-Lapa MA, Monteiro AW et al: NF-kB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. PLoS One, 2012; 7(12): e52010
65. Girdler SS, Klatzkin R: Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol Ther, 2007; 116(1): 125–39
66. Patten SB, Wang JL, Williams JV et al: Predictors of the longitudinal course of major depression in a Canadian population sample. Can J Psychiatry, 2010; 55(10): 669–76
67. Whittle S, Yap MB, Sheeber L et al: Hippocampal volume and sensitivity to maternal aggressive behavior: A prospective study of adolescent depressive symptoms. Dev Psychopathol, 2011; 23(1): 115–29
68. Vreeburg SA, Hoogendijk WJ, van Pelt J et al: Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: Results from a large cohort study. Arch Gen Psychiatry, 2009; 66(6): 617–26
69. Porter RJ, Gallagher P: Abnormalities of the HPA axis in affective disorders: Clinical subtypes and potential treatments. Acta Neuropsychiatr, 2006; 18: 193–209
70. Egeland J, Lund A, Landro NI et al: Cortisol level predicts executive and memory function in depression, symptom level predicts psychomotor speed. Acta Psychiatr Scand, 2005; 112(6): 434–41
71. Pavlides C, Nivon LG, McEwen BS: Effects of chronic stress on hippocampal long-term potentiation. Hippocampus, 2002; 12: 245–57
72. Lee HY, Lee GH, Marahatta A et al: The protective role of Bax inhibitor-1 against chronic mild stress through the inhibition of monoamine oxidase A. Sci Rep, 2013; 3: 3398
73. Anderson G, Kubera M, Duda W et al: Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression. Pharmacol Rep, 2013; 65(6): 1647–54
74. Konarski JZ, McIntyre RS, Kennedy SH et al: Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord, 2008; 10: 1–37
75. Monkul ES, Malhi GS, Soares JC: Mood disorders – review of structural MRI studies. Acta Neuropsychiatr, 2003; 15: 368–80
76. Anderson G, Rodriguez M: Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin. Eur J Neurol, 2001; 18(5): 680–85
77. Drevets WC: Orbitofrontal Cortex Function and Structure in Depression. Ann NY Acad Sci, 2007; 1121: 499–527
78. MacMaster FP, Mirza Y, Szeszko PR et al: Amygdala and hippocampal volumes in familial early onset major depressive disorder. Biol Psychiatry, 2008; 63: 385–90
79. Ebmeier KP, Donaghey C, Steele JD: Recent developments and current controversies in depression. Lancet, 2006; 367: 153–67
80. Fuchs E, Flugge G: Social stress in tree shrews: effect on physiology, brain function and behavior of subordinate individuals. Pharmacol Biochem Behav, 2002; 73: 247–58
81. Spalletta G, Guida G, Caltagirone C: Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance? J Neurol, 2003; 250: 449–55
82. Noesselt T, Driver J, Heinze HJ, Dolan R: Asymmetrical activation in the human brain during processing of fearful faces. Curr Biol, 2005; 15: 424–29
83. Mayberg HS, Liotti M, Brannan SK et al: Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. Am J Psychiatry, 1999; 156: 675–82
84. Peterson BS, Warner V, Bansal R, Hongtu Z: Cortical thinning in persons at increased familial risk for major depression. Proc Natl Acad Sci USA, 2009; 15: 6273–78
85. Hsu DT, Langenecker SA, Kennedy SE et al: fMRI BOLD responses to negative stimuli in the prefrontal cortex are dependent on levels of recent negative life stress in major depressive disorder. Psychiatry Res, 2010; 183(3): 202–8
86. Langenecker SA, Kennedy SE, Guidotti LM et al: Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder. Biol Psychiatry, 2007; 62: 1272–80
87. Zabłocka A: Alzheimer’s disease as neurodegenerative disorder. Postepy Hig Med Dosw, 2006; 60: 209–16
88. Alexopoulos GS, Morimoto SS: The inflammation hypothesis in geriatric depression. Int J Geriatr Psychiatry, 2011; 26(11): 1109–18
89. Canon ME, Crimmins EM: Sex differences in the association between muscle quality, inflammatory markers, and cognitive decline. J Nutr Health Aging, 2011; 15(8): 695–98
90. Maes M, Kubera M, Leunis JC et al: In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand, 2013; 127(5): 344–54
91. Bossu P, Cutuli D, Palladino I et al: A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-alpha and IL-18. J Neuroinflammation, 2012; 9(1): 101
92. Pontes GN, Cardoso EC, Carneiro-Sampaio MM, Markus RP: Pineal melatonin and the innate immune response: the TNF-alpha increase after caesarean section suppress nocturnal melatonin production. J Pineal Res, 2007; 43: 365–71
93. Insel KC, Moore IM, Vidrine AN, Montgomery DW: Biomarkers for cognitive aging-part II: oxidative stress, cognitive assessments, and medication adherence. Biol Res Nurs. Biol Res Nurs, 2012; 14(2): 133–38
94. Maes M, Berk M, Goehler L et al: Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med, 2012; 10: 66
95. Gałecki P, Florkowski A, Bobińska K et al: Functional polymorphismof the myeloperoxidase gene (G-463A) in depressive patients. Acta Neuropsychiatr, 2010; 5: 218–22
96. Sarandol A, Sarandol E, Eker SS et al: Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol, 2007; 22: 67–73
97. Catena-Dell’Osso M, Bellantuono C, Consoli G et al: Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem, 2011; 18(2): 245–55
98. Marsland AE, Gianaros PJ, Abramowitch SM et al: Interleukin- 6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry, 2008; 64: 484–90
99. Cubała WJ, Godlewska B, Trzonkowski P, Landowski J: Indicators of the persistent pro-inflammatory activation of the immune system in depression. Psychiatr Pol, 2006; 40(3): 431–44
100. Padurariu M, Ciobica A, Hritcu L et al: Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease. Neurosci Lett, 2010; 469(1): 6–10
101. Baune BT, Unwin SJ, Quirk F, Golledge J: Neuropsychiatric symptoms in patients with aortic aneurysms. PLoS One, 2011; 6(7): e22632
102. Talarowska M, Florkowski A, Gałecki P et al: [The impact of psychological variables on the presentation and progress of asthma and patient’s cognitive functions]. Pneumonol Alergol Pol 2009; 77: 554–59 [in Polish].
103. Talarowska M, Florkowski A, Zboralski K, Gałecki P: Cognitive functions and clinical features among diabetic patients in Polish population. Cent Eur J Med, 2009; 4(4): 467–75
104. Talarowska M, Gałecki P, Maes M et al: Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder. Mol Biol Rep, 2012; 39(5): 5359–66
105. Talarowska M, Gałecki P, Maes M et al: Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder. Neurosci Lett, 2012; 510(2): 127–31
106. Gałecki P, Talarowska M, Bobińska K et al: Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder. Neuro Endocrinol Lett, 2013; 34(8): 780–86
107. Talarowska M, Gałecki P, Maes M et al: Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder. Neurochem Res, 2012; 37(8): 1761–67
108. Airaksinen E, Wahlin A, Forsell Y, Larsson M: Low episodic memory performance as a premorbid marker of depression: evidence from a 3-year follow- up. Acta Psychiatr Scand, 2007; 115(6): 458–65
109. Han L, McCusker J, Abrahamowicz M et al: The temporal relationship between depression symptoms and cognitive functioning in older medical patients-prospective or concurrent? J Geront, 2006; 61A: 1319–23
110. Wilson R, Mendes de Leon C, Bennett D et al: Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry, 2004; 75: 126–29
111. Talarowska M, Zboralski K, Gałecki P: Correlations between working memory effectiveness and depression levels after pharmacological therapy. Psychiatr Pol, 2013; 47(2): 255–67
112. Harvey PO, Le Bastard G, Pochon JB et al: Executive functions and updating of the contents of working memory in unipolar depression. J Psychiatr Res, 2004; 38: 567–76
113. Naismith SL, Longley WA, Scott EM, Hickie IB: Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry, 2007; 7: 32–40
114. Anderson G, Maes M: Neurodegeneration in Parkinson’s disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol Neurobiol, 2014; 49(2): 771–83
115. Takami H, Okamoto Y, Yamashita H et al: Attenuated anterior cingulate activation during a verbal fluency task in elderly patients with a history of multiple-episode depression. Am J Geriatr Psychiatry, 2007; 15(7): 594–603
116. Talarowska M, Florkowski A, Zboralski K, Gałecki P: Cognitive functions impairment depending on clinical traits of unipolar recurrent depression – preliminary rsults. Psychiatria Psychoterapia, 2010; 6(1): 11–18
117. Biringer E, Lundervold A, Stordal K et al: Executive function improvement upon remission of recurrent unipolar depression. Eur Arch Psychiatry Clin Neurosci, 2005; 255: 373–80
118. Biringer E, Lundervold A, Stordal K et al: Executive function improvement upon remission of recurrent unipolar depression. Eur Arch Psychiatry Clin Neurosci, 2005; 255: 373–80
119. Okada G, Okamoto Y, Yamashita H et al: Attenuated prefrontal activation during a verbal fluency task in remitted major depression. Psychiatry Clin Neurosci, 2009; 63(3): 423–25
120. Alexopoulos GS, Kiosses DN, Heo M et al: Executive dysfunction and the course of geriatric depression. Biol Psychiatry, 2005; 58: 204–10
121. Anderson G, Maes M: Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications. Curr Pharm Des, 2013; 20(23): 3812–47
122. Tanaka M, Ishii A, Yamano E et al: Cognitive dysfunction in elderly females with depressive symptoms. Med Sci Monit, 2012; 18(12): CR706–11
123. Morris G, Anderson G, Dean O et al: The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol, 2014; 50(3): 1059–84
124. Borkowska A, Rybakowski JK: Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Dis, 2001; 3: 88–94